Carlos I Ayala-Navarro, MD PhD (@ciaborisurgeon) 's Twitter Profile
Carlos I Ayala-Navarro, MD PhD

@ciaborisurgeon

Husband (Esposo), dad (papa), @StanfordSurgery @OpNotes gen surg alumn, CGSO fellow @moffittnews, Boricua🇵🇷

ID: 1636805820632666112

calendar_today17-03-2023 19:05:01

249 Tweet

525 Followers

723 Following

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Stop by Carlos Ayala-Navarro, MD, PhD (Carlos I Ayala-Navarro, MD PhD)’s poster tomorrow at #SSO2025 to explore the immunosuppressed microenvironment and mucin infiltration in appendiceal cancers through multiplex immunofluorescence analysis. 📍 HUB Poster Park #MoffittSSO25

Stop by Carlos Ayala-Navarro, MD, PhD (<a href="/CIABoriSurgeon/">Carlos I Ayala-Navarro, MD PhD</a>)’s poster tomorrow at #SSO2025 to explore the immunosuppressed microenvironment and mucin infiltration in appendiceal cancers through multiplex immunofluorescence analysis.

📍 HUB Poster Park

#MoffittSSO25
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Happening now at #SSO2025 Michael Wach, MD (Mike Wach MD) discusses Intra-tumoral mucolytic therapy for patients with unresectable pseudomyxoma peritonei, results of an expanded access program. #MoffittSSO25 Society of Surgical Oncology KEY FINDINGS: ➡️ BromAc treatment within tumors is a

Happening now at #SSO2025 Michael Wach, MD (<a href="/MikeWach_MD/">Mike Wach MD</a>) discusses Intra-tumoral mucolytic therapy for patients with unresectable pseudomyxoma peritonei, results of an expanded access program. #MoffittSSO25 <a href="/SocSurgOnc/">Society of Surgical Oncology</a>

KEY FINDINGS: 

➡️ BromAc treatment within tumors is a
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

During #SSO2025 Carlos Ayala-Navarro (Carlos I Ayala-Navarro, MD PhD) presents on immune microenvironment in appendiceal cancers. Key findings include increased MUC2 cells in tumors, reduced populations of B, T, and regulatory T cells, and an increased presence of neutrophils, macrophages, and

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At #SSO2025, Apeksha Dave, MD (Apeksha) discusses a study looking at why patients with pathologic complete response after total neoadjuvant treatment for LARC still underwent TME, highlighting the need for better evaluation methods to avoid unnecessary surgeries.

Carlos I Ayala-Navarro, MD PhD (@ciaborisurgeon) 's Twitter Profile Photo

Appendiceal tumors are rare and understudied. These are our efforts to elucidate the role the TME, in particular neutrophils and macrophages, plays in their development and progression to peritoneal metastasis.

Carlos I Ayala-Navarro, MD PhD (@ciaborisurgeon) 's Twitter Profile Photo

Meeting Dr Gronchi Alessandro Gronchi and learning about all the moving pieces and efforts that led to the creation of TARPSWG was very inspirational. More importantly all the discoveries and lessons that have followed the creation of the collaborative group.

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Live from #SSO2025: Jonathan Zager, MD (Jonathan Zager, MD) explores the latest FDA-approved treatments for liver-directed therapy in melanoma, including Percutaneous Liver Perfusion (PHP) and the Hepzato Kit, and discusses the best approaches for their use. #MoffittSSO25

Live from #SSO2025: Jonathan Zager, MD (<a href="/jzager99/">Jonathan Zager, MD</a>) explores the latest FDA-approved treatments for liver-directed therapy in melanoma, including Percutaneous Liver Perfusion (PHP) and the Hepzato Kit, and discusses the best approaches for their use. #MoffittSSO25
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Training Program Director, Sean Dineen, MD, kicks off the Tampa Bay Surgical Oncology Society Special Symposium with exciting updates on Moffitt’s Complex Surgical Oncology (CGSO) Fellowship, which has grown significantly over the past 30 years alongside rising patient volumes.

Training Program Director, Sean Dineen, MD, kicks off the Tampa Bay Surgical Oncology Society Special Symposium with exciting updates on Moffitt’s Complex Surgical Oncology (CGSO) Fellowship, which has grown significantly over the past 30 years alongside rising patient volumes.
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Next at the Tampa Bay Surgical Oncology Society Special Symposium, Jason Denbo, MD, (Jason W Denbo) shares insights on advancing liver surgery, focusing on 3D reconstruction and surgeon-directed volumetry. Key points: • Liver volumetry is essential. Surgeon-directed volumetry is an

Next at the Tampa Bay Surgical Oncology Society Special Symposium, Jason Denbo, MD, (<a href="/DenboJw/">Jason W Denbo</a>) shares insights on advancing liver surgery, focusing on 3D reconstruction and surgeon-directed volumetry.

Key points:
• Liver volumetry is essential. Surgeon-directed volumetry is an
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At the Tampa Bay Surgical Oncology Society Special Symposium, Sean Dineen, MD, offers insight into the development of a clinical and academic peritoneal surface malignancy program. He highlights Moffitt’s multidisciplinary approach for each patient’s needs to determine the best

At the Tampa Bay Surgical Oncology Society Special Symposium, Sean Dineen, MD, offers insight into the development of a clinical and academic peritoneal surface malignancy program. He highlights Moffitt’s multidisciplinary approach for each patient’s needs to determine the best
Dr. Patrick Hwu (@patrickhwumd) 's Twitter Profile Photo

At #SSO2025, Sean Dineen, MD, joined me to discuss the advanced techniques used to treat peritoneal disease, which is a rare manifestation where cancer spreads from its site of origin into the lining of the abdominal cavity. #MoffittSSO25

Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Clinical Trial Aims to Find Better Treatment Option for Rare Small Bowel Cancer | Moffitt moffitt.org/endeavor/archi…

American College of Surgeons (@amcollsurgeons) 's Twitter Profile Photo

While bile duct injuries are rare, their rates have increased since the widespread use of laparoscopic cholecystectomies began in the early 1990s. In the May Bulletin, experts discuss how to engage in the "Critical View of Safety" during the procedure. brnw.ch/21wSudL

Samantha Seitter (@drseitter) 's Twitter Profile Photo

Great talk here at the #MoffittCancerSymposium by my co-fellow Dr Gazivoda discussing our experience with robotic-assisted prophylactic total gastrectomy for patients with CDH1 mutations Moffitt Cancer Center

Great talk here at the #MoffittCancerSymposium by my co-fellow Dr Gazivoda  discussing our experience with robotic-assisted prophylactic total gastrectomy for patients with  CDH1 mutations <a href="/MoffittNews/">Moffitt Cancer Center</a>